RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/s-0042-1742581
Role of MRI in Treatment Planning of Endometrial CA
Abstract
Purpose Endometrial carcinoma is a major cause of morbidity and mortality in women. It is the fourth most common cancer in women and its incidence is rising. Clinical examination and endometrial sampling form the mainstay of diagnosis. Magnetic resonance imaging (MRI) due to its superb soft tissue contrast can play an important role in the management of the disease. The present article reviews the role of MRI to exclude mimics, confirm the diagnosis, stage the disease, and in the follow-up of a patient with carcinoma of the endometrium.
Method Using online databases including PubMed and Medline, literature was reviewed to assess the role of MRI to confirm the diagnosis, stage the disease, and follow-up in a patient of carcinoma endometrium. The examples published were taken from a personal file of cases.
Results MRI with newer sequences like dynamic contrast studies and diffusion-weighted imaging can play an important role in excluding mimics, staging, and in the follow-up of the patient.
Conclusion MRI with advanced sequences is the imaging modality of choice in pre- and postoperative evaluation of patients with endometrial carcinoma. It is the most sensitive imaging modality to evaluate myometrial invasion and early involvement of the cervix.
Publikationsverlauf
Artikel online veröffentlicht:
19. September 2023
© 2022. Indographics. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Cancer Report FIGO. 2018 | Figo. Accessed October 17, 2020 at: https://www.figo.org/resources/figo-cancer-report-2018
- 2 Lewin SN. Revised FIGO staging system for endometrial cancer. Clin Obstet Gynecol 2011; 54 (02) 215-218
- 3 Freeman SJ, Aly AM, Kataoka MY, Addley HC, Reinhold C, Sala E. The revised FIGO staging system for uterine malignancies: implications for MR imaging. Radiographics 2012; 32 (06) 1805-1827
- 4 Frei KA, Kinkel K. Staging endometrial cancer: role of magnetic resonance imaging. J Magn Reson Imaging 2001; 13 (06) 850-855
- 5 Cade TJ, Quinn MA, McNally OM, Neesham D, Pyman J, Dobrotwir A. Predictive value of magnetic resonance imaging in assessing myometrial invasion in endometrial cancer: is radiological staging sufficient for planning conservative treatment?. Int J Gynecol Cancer 2010; 20 (07) 1166-1169
- 6 Sanjuán A, Escaramís G, Ayuso JR. et al. Role of magnetic resonance imaging and cause of pitfalls in detecting myometrial invasion and cervical involvement in endometrial cancer. Arch Gynecol Obstet 2008; 278 (06) 535-539
- 7 Manfredi R, Gui B, Maresca G, Fanfani F, Bonomo L. Endometrial cancer: magnetic resonance imaging. Abdom Imaging 2005; 30 (05) 626-636
- 8 Querleu D, Planchamp F, Narducci F. et al; Institut National du Cancer, Societe Francaise d'Oncologie Gynecologique. Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut National du Cancer and the Société Française d'Oncologie Gynécologique. Int J Gynecol Cancer 2011; 21 (05) 945-950
- 9 Husband JE, Padhani A. Royal Royal College of Radiologists. Recommendations for Cross-Sectional Imaging in Cancer Management. London: Royal College of Radiologists; , 2006 (issue 2)
- 10 Kinkel K, Forstner R, Danza FM. et al; European Society of Urogenital Imaging. Staging of endometrial cancer with MRI: guidelines of the European Society of Urogenital Imaging. Eur Radiol 2009; 19 (07) 1565-1574
- 11 Haldorsen IS, Salvesen HB. Staging of endometrial carcinomas with MRI using traditional and novel MRI techniques. Clin Radiol 2012; 67 (01) 2-12
- 12 Haldorsen IS, Husby JA, Werner HMJ. et al. Standard 1.5-T MRI of endometrial carcinomas: modest agreement between radiologists. Eur Radiol 2012; 22 (07) 1601-1611
- 13 Rechichi G, Galimberti S, Signorelli M, Perego P, Valsecchi MG, Sironi S. Myometrial invasion in endometrial cancer: diagnostic performance of diffusion-weighted MR imaging at 1.5-T. Eur Radiol 2010; 20 (03) 754-762
- 14 Lee JH, Dubinsky T, Andreotti RF. et al; Expert Panel on Women's Imaging and Radiation Oncology-Gynecology. ACR appropriateness Criteria® pretreatment evaluation and follow-up of endometrial cancer of the uterus. Ultrasound Q 2011; 27 (02) 139-145
- 15 Koh W, Abu-Rustum NR, Bean S. et al. Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2018; 16 (02) 170-199
- 16 Karlsson B, Granberg S, Wikland M. et al. Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding–a Nordic multicenter study. Am J Obstet Gynecol 1995; 172 (05) 1488-1494
- 17 McCarthy S, Scott G, Majumdar S. et al. Uterine junctional zone: MR study of water content and relaxation properties. Radiology 1989; 171 (01) 241-243
- 18 Scoutt LM, Flynn SD, Luthringer DJ, McCauley TR, McCarthy SM. Junctional zone of the uterus: correlation of MR imaging and histologic examination of hysterectomy specimens. Radiology 1991; 179 (02) 403-407
- 19 Sala E, Wakely S, Senior E, Lomas D. MRI of malignant neoplasms of the uterine corpus and cervix. AJR Am J Roentgenol 2007; 188 (06) 1577-1587
- 20 Chaudhry S, Reinhold C, Guermazi A, Khalili I, Maheshwari S. Benign and malignant diseases of the endometrium. Top Magn Reson Imaging 2003; 14 (04) 339-357
- 21 Beddy P, O'Neill AC, Yamamoto AK, Addley HC, Reinhold C, Sala E. FIGO staging system for endometrial cancer: added benefits of MR imaging. Radiographics 2012; 32 (01) 241-254
- 22 Yamashita Y, Harada M, Sawada T, Takahashi M, Miyazaki K, Okamura H. Normal uterus and FIGO stage I endometrial carcinoma: dynamic gadolinium-enhanced MR imaging. Radiology 1993; 186 (02) 495-501
- 23 Sala E, Crawford R, Senior E. et al. Added value of dynamic contrast-enhanced magnetic resonance imaging in predicting advanced stage disease in patients with endometrial carcinoma. Int J Gynecol Cancer 2009; 19 (01) 141-146
- 24 Sala E, Rockall A, Rangarajan D, Kubik-Huch RA. The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis. Eur J Radiol 2010; 76 (03) 367-385
- 25 Sironi S, Colombo E, Villa G. et al. Myometrial invasion by endometrial carcinoma: assessment with plain and gadolinium-enhanced MR imaging. Radiology 1992; 185 (01) 207-212
- 26 Punwani S. Diffusion weighted imaging of female pelvic cancers: concepts and clinical applications. Eur J Radiol 2011; 78 (01) 21-29
- 27 Levy A, Medjhoul A, Caramella C. et al. Interest of diffusion-weighted echo-planar MR imaging and apparent diffusion coefficient mapping in gynecological malignancies: a review. J Magn Reson Imaging 2011; 33 (05) 1020-1027
- 28 Tamai K, Koyama T, Saga T. et al. Diffusion-weighted MR imaging of uterine endometrial cancer. J Magn Reson Imaging 2007; 26 (03) 682-687
- 29 Lin G, Ng KK, Chang CJ. et al. Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging–initial experience. Radiology 2009; 250 (03) 784-792
- 30 Shen SH, Chiou YY, Wang JH. et al. Diffusion-weighted single-shot echo-planar imaging with parallel technique in assessment of endometrial cancer. AJR Am J Roentgenol 2008; 190 (02) 481-488
- 31 Rockall AG, Meroni R, Sohaib SA. et al. Evaluation of endometrial carcinoma on magnetic resonance imaging. Int J Gynecol Cancer 2007; 17 (01) 188-196
- 32 Mariani A, Webb MJ, Keeney GL, Podratz KC. Routes of lymphatic spread: a study of 112 consecutive patients with endometrial cancer. Gynecol Oncol 2001; 81 (01) 100-104
- 33 Berman ML, Ballon SC, Lagasse LD, Watring WG. Prognosis and treatment of endometrial cancer. Am J Obstet Gynecol 1980; 136 (05) 679-688
- 34 Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 1987; 60 (8, Suppl): 2035-2041
- 35 Larson DM, Connor GP, Broste SK, Krawisz BR, Johnson KK. Prognostic significance of gross myometrial invasion with endometrial cancer. Obstet Gynecol 1996; 88 (03) 394-398
- 36 He H, Bhosale P, Wei W, Ramalingam P, Iyer R. MRI is highly specific in determining primary cervical versus endometrial cancer when biopsy results are inconclusive. Clin Radiol 2013; 68 (11) 1107-1113
- 37 Bourgioti C, Chatoupis K, Panourgias E. et al. Endometrial vs. cervical cancer: development and pilot testing of a magnetic resonance imaging (MRI) scoring system for predicting tumor origin of uterine carcinomas of indeterminate histology. Abdom Imaging 2015; 40 (07) 2529-2540
- 38 Çavuşoğlu M, Sözmen Ciliz D, Ozsoy A. et al. Diffusion-weighted MRI of postmenopausal women with vaginal bleeding and endometrial thickening: differentiation of benign and malignant lesions. J Belg Soc Radiol 2016; 100 (01) 70
- 39 Fujii S, Matsusue E, Kigawa J. et al. Diagnostic accuracy of the apparent diffusion coefficient in differentiating benign from malignant uterine endometrial cavity lesions: initial results. Eur Radiol 2008; 18 (02) 384-389
- 40 Takeuchi M, Matsuzaki K, Nishitani H. Diffusion-weighted magnetic resonance imaging of endometrial cancer: differentiation from benign endometrial lesions and preoperative assessment of myometrial invasion. Acta Radiol 2009; 50 (08) 947-953
- 41 Hase S, Mitsumori A, Inai R. et al. Endometrial polyps: MR imaging features. Acta Med Okayama 2012; 66 (06) 475-485